Company Filing History:
1 out of 27,320 
1 out of 208 
1 out of 3,101 
Years Active: 2012-2021
Title: Yi Wei - Innovator in Electronic Devices and Health Solutions
Introduction
Yi Wei is a prominent inventor based in Shanghai, China. He has made significant contributions to the fields of electronic devices and health solutions. With a total of two patents to his name, his work focuses on reducing power consumption in electronic devices and developing inhibitors for protein tyrosine phosphatase 1B.
Latest Patents
Yi Wei's latest patents include an electronic device capable of reducing power consumption and a method for reducing power consumption of electronic devices. This invention features a processor, volatile memory, and non-volatile memory. The non-volatile memory stores a first operating system, allowing the device to operate in two modes. When the device detects a preset condition, it transitions to a second working mode, optimizing power usage.
Another notable patent is for a protein tyrosine phosphatase 1B inhibitor, which has shown effectiveness in inhibiting the activity of PTP1B. These inhibitors can serve as insulin sensitizers and may be used to prevent, delay, or treat diseases related to insulin antagonism, particularly type II diabetes and obesity. The invention also outlines methods for preparing these inhibitors.
Career Highlights
Throughout his career, Yi Wei has worked with notable organizations such as Huawei Technologies Co., Limited and Fudan University. His experience in these institutions has allowed him to develop innovative solutions that address both technological and health-related challenges.
Collaborations
Yi Wei has collaborated with several professionals in his field, including RenHua Yang and Junfeng Zhao. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Yi Wei's contributions to electronic devices and health solutions highlight his innovative spirit and dedication to improving technology and health outcomes. His patents reflect a commitment to addressing critical issues in power consumption and diabetes management.